Myomo (MYO)
(Delayed Data from AMEX)
$3.83 USD
+0.27 (7.58%)
Updated May 10, 2024 04:00 PM ET
After-Market: $3.84 +0.01 (0.26%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Income Statements
Fiscal Year end for Myomo, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 19 | 16 | 14 | 8 | 4 |
Cost Of Goods | 6 | 5 | 4 | 3 | 1 |
Gross Profit | 13 | 10 | 10 | 5 | 3 |
Selling & Adminstrative & Depr. & Amort Expenses | 21 | 21 | 21 | 15 | 14 |
Income After Depreciation & Amortization | -8 | -11 | -10 | -11 | -11 |
Non-Operating Income | 0 | 0 | 0 | -1 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -8 | -11 | -10 | -12 | -11 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -8 | -11 | -10 | -12 | -11 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -8 | -11 | -10 | -12 | -11 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -8 | -10 | -10 | -10 | -11 |
Depreciation & Amortization (Cash Flow) | 0 | 1 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -8 | -11 | -10 | -11 | -11 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 29.50 | 7.05 | 5.83 | 3.33 | 0.55 |
Diluted EPS Before Non-Recurring Items | -0.28 | -1.52 | -1.89 | -3.46 | -19.35 |
Diluted Net EPS (GAAP) | -0.28 | -1.52 | -1.89 | -3.67 | -19.35 |
Fiscal Year end for Myomo, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 4.76 | 5.08 | 5.96 | 3.45 |
Cost Of Goods | NA | 1.65 | 1.59 | 1.68 | 1.14 |
Gross Profit | NA | 3.10 | 3.49 | 4.28 | 2.31 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 5.54 | 5.52 | 5.38 | 4.98 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -2.44 | -2.03 | -1.10 | -2.67 |
Non-Operating Income | NA | 0.04 | 0.04 | 0.09 | 0.07 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -2.39 | -1.98 | -1.02 | -2.60 |
Income Taxes | NA | 0.07 | 0.05 | 0.00 | 0.04 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -2.46 | -2.03 | -1.01 | -2.64 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -2.46 | -2.03 | -1.01 | -2.64 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 35.18 | 35.27 | 27.99 | 24.20 |
Diluted EPS Before Non-Recurring Items | NA | -0.07 | -0.06 | -0.04 | -0.11 |
Diluted Net EPS (GAAP) | NA | -0.07 | -0.06 | -0.04 | -0.11 |